Sun Eric C, Darnall Beth D, Baker Laurence C, Mackey Sean
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California3National Bureau of Economic Research, Cambridge, Massachusetts.
JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298.
Chronic opioid use imposes a substantial burden in terms of morbidity and economic costs. Whether opioid-naive patients undergoing surgery are at increased risk for chronic opioid use is unknown, as are the potential risk factors for chronic opioid use following surgery.
To characterize the risk of chronic opioid use among opioid-naive patients following 1 of 11 surgical procedures compared with nonsurgical patients.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of administrative health claims to determine the association between chronic opioid use and surgery among privately insured patients between January 1, 2001, and December 31, 2013. The data concluded 11 surgical procedures (total knee arthroplasty [TKA], total hip arthroplasty, laparoscopic cholecystectomy, open cholecystectomy, laparoscopic appendectomy, open appendectomy, cesarean delivery, functional endoscopic sinus surgery [FESS], cataract surgery, transurethral prostate resection [TURP], and simple mastectomy). Multivariable logistic regression analysis was performed to control for possible confounders, including sex, age, preoperative history of depression, psychosis, drug or alcohol abuse, and preoperatice use of benzodiazepines, antipsychotics, and antidepressants.
One of the 11 study surgical procedures.
Chronic opioid use, defined as having filled 10 or more prescriptions or more than 120 days' supply of an opioid in the first year after surgery, excluding the first 90 postoperative days. For nonsurgical patients, chronic opioid use was defined as having filled 10 or more prescriptions or more than 120 days' supply following a randomly assigned "surgery date."
The study included 641 941 opioid-naive surgical patients (169 666 men; mean [SD] age, 44.0 [12.8] years), and 18 011 137 opioid-naive nonsurgical patients (8 849 107 men; mean [SD] age, 42.4 [12.6] years). Among the surgical patients, the incidence of chronic opioid in the first preoperative year ranged from 0.119% for Cesarean delivery (95% CI, 0.104%-0.134%) to 1.41% for TKA (95% CI, 1.29%-1.53%) The baseline incidence of chronic opioid use among the nonsurgical patients was 0.136% (95% CI, 0.134%-0.137%). Except for cataract surgery, laparoscopic appendectomy, FESS, and TURP, all of the surgical procedures were associated with an increased risk of chronic opioid use, with odds ratios ranging from 1.28 (95% CI, 1.12-1.46) for cesarean delivery to 5.10 (95% CI, 4.67-5.58) for TKA. Male sex, age older than 50 years, and preoperative history of drug abuse, alcohol abuse, depression, benzodiazepine use, or antidepressant use were associated with chronic opioid use among surgical patients.
In opioid-naive patients, many surgical procedures are associated with an increased risk of chronic opioid use in the postoperative period. A certain subset of patients (eg, men, elderly patients) may be particularly vulnerable.
长期使用阿片类药物会带来巨大的发病负担和经济成本。初次使用阿片类药物的手术患者是否有更高的长期使用阿片类药物风险尚不清楚,术后长期使用阿片类药物的潜在风险因素也不清楚。
描述11种外科手术之一后的初次使用阿片类药物患者与非手术患者相比长期使用阿片类药物的风险。
设计、背景和参与者:对管理式医疗索赔进行回顾性分析,以确定2001年1月1日至2013年12月31日期间私人保险患者中慢性阿片类药物使用与手术之间的关联。数据包括11种外科手术(全膝关节置换术[TKA]、全髋关节置换术、腹腔镜胆囊切除术、开腹胆囊切除术、腹腔镜阑尾切除术、开腹阑尾切除术、剖宫产、功能性鼻内镜鼻窦手术[FESS]、白内障手术、经尿道前列腺切除术[TURP]和单纯乳房切除术)。进行多变量逻辑回归分析以控制可能的混杂因素,包括性别、年龄、术前抑郁症、精神病、药物或酒精滥用病史,以及术前使用苯二氮卓类药物、抗精神病药物和抗抑郁药物。
11种研究性外科手术之一。
长期使用阿片类药物,定义为术后第一年开具10张或更多阿片类药物处方或供应量超过120天,但不包括术后前90天。对于非手术患者,长期使用阿片类药物定义为在随机指定的“手术日期”后开具10张或更多处方或供应量超过120天。
该研究纳入了641941名初次使用阿片类药物的手术患者(169666名男性;平均[标准差]年龄,44.0[12.8]岁),以及18011137名初次使用阿片类药物的非手术患者(8849107名男性;平均[标准差]年龄,42.4[12.6]岁)。在手术患者中,术前第一年慢性阿片类药物的发生率从剖宫产的0.119%(95%CI,0.104%-0.134%)到全膝关节置换术的1.41%(95%CI,1.29%-1.53%)不等。非手术患者中慢性阿片类药物使用的基线发生率为0.136%(95%CI,0.134%-0.137%)。除白内障手术、腹腔镜阑尾切除术、功能性鼻内镜鼻窦手术和经尿道前列腺切除术后,所有手术均与慢性阿片类药物使用风险增加相关联,比值比范围从剖宫产的1.28(95%CI,1.12-1.46)到全膝关节置换术的5.10(95%CI,4.67-5.58)。男性、50岁以上年龄以及术前药物滥用、酒精滥用、抑郁症、苯二氮卓类药物使用或抗抑郁药物使用病史与手术患者慢性阿片类药物使用相关。
在初次使用阿片类药物的患者中,许多外科手术与术后慢性阿片类药物使用风险增加相关。特定亚组患者(如男性患者、老年患者)可能特别易受影响。